Navigation Links
Medpace Opens Clinical Pharmacology Unit in Cincinnati, Ohio
Date:12/18/2007

CINCINNATI, Dec. 18 /PRNewswire/ -- Medpace, a leading global full-service contract research organization (CRO), is opening a 50 bed clinical pharmacology unit in Cincinnati, Ohio. The Medpace Clinical Pharmacology Unit (Medpace CPU) is a state-of-the-art Phase I, IIa facility, focusing on confined/controlled pharmacokinetic/pharmacodynamic studies utilizing human volunteers, with first-in-man capability.

The Medpace CPU is led by Jean Siebenaler, MD, who has extensive experience in clinical practice and CRO project management. The Medpace CPU will be managed by a team of highly trained, clinical research professionals, who are experts in the design, implementation, and analysis of Phase I and IIa studies. Jim Wei, MD, PhD, will be responsible for reviewing the early Phase studies of sponsors' products, recommending studies, and assisting with Phase I/Phase IIa study designs. Dr. Wei comes to Medpace from the FDA where he served as a Senior Reviewer in the Office of Clinical Pharmacology for almost 10 years where he was heavily involved in reviewing NDAs and INDs for the Divisions of Metabolism and Endocrinology Products.

Aligned with the Medpace approach of providing therapeutically focused clinical development services, the Medpace CPU will uniquely focus on studies in defined metabolic patient populations. The company's dedicated subject recruitment division, together with a strategic partnership with the renowned Metabolic and Atherosclerosis Research Center (MARC) led by Dr. Evan Stein, will facilitate efficient recruitment of populations which include: diabetics (Types I and II), patients with metabolic syndromes and cardiovascular diseases.

The secure, state-of-the-art, 24-hour, 7-day a week facility, features a thirteen bed intensive care/observation unit. The Medpace CPU is located across the street from the Medpace Reference Laboratories, a full service central lab which features therapeutically specialized testing. The site wil
'/>"/>

SOURCE Medpace
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
2. Kosan Opens Registration Program for Lead Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma
3. New Risk Gene for Rheumatoid Arthritis and Lupus Opens Door to More Effective Treatments
4. Global HIV Vaccine Enterprise Names Alan Bernstein as Inaugural Executive Director, Opens New Secretariat
5. PPD Opens Offices in Sydney, Australia; Copenhagen, Denmark; Lima, Peru; and Lisbon, Portugal
6. Pilot Study Opens the Door for Avastin Use in Curative Setting for Women With Breast Cancer
7. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
8. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
9. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
10. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
11. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)...Newswire-FirstCall/ -- Booth - 3646/South Hall A -...emier supplier of X-ray tubes and flat panel digit... detectors at the RSNA Annual Meeting in Chicago, ...will also be exhibiting X-ray tube technology for ...treatment technologies. ,, Varian,s exhibit wi...
(Date:11/27/2009)...re/ -- At the upcoming Radiological Society of Nor...Royal Philips Electronics ( PHG, AEX: PHI) will de...formatics solutions designed to directly address t...elivering meaningful imaging innovations that refl...asy upgradability. This focus will enable Philips...
(Date:11/25/2009)... Praxis Electronic Medical Records...demy of Family Physicians, (AAFP) Family Practice ... for improving medical quality, health maintenance...A Stimulus legislation. Praxis also ranked #1 amon...ct in determining their salary. Finally, Praxis al...
Breaking Medicine Technology:Varian Medical Systems to Highlight the Latest Digital Detectors, X-ray Tubes and Cancer Treatment Technology at the Radiological Society of North America (RSNA) Annual Meeting in Chicago 2Philips Helps Hospitals Strike Balance Between Innovation and Value 2Philips Helps Hospitals Strike Balance Between Innovation and Value 3Philips Helps Hospitals Strike Balance Between Innovation and Value 4Praxis EMR Wins Top Rankings in 2009 AAFP EHR User Satisfaction Survey 2Novavax Awarded NIH Grant for Respiratory Syncytial Virus 28RSV 29 Vaccine Program 14447 1Novavax Awarded NIH Grant for Respiratory Syncytial Virus 28RSV 29 Vaccine Program 14447 2Novavax Awarded NIH Grant for Respiratory Syncytial Virus 28RSV 29 Vaccine Program 14447 3Resverlogix Appoints A Brad Cann as Chief Financial Officer 14444 1Resverlogix Appoints A Brad Cann as Chief Financial Officer 14444 2Resverlogix Appoints A Brad Cann as Chief Financial Officer 14444 3Accuray Incorporated to Present at 20th Annual Oppenheimer Healthcare Conference 5430 1Accuray Incorporated to Present at 20th Annual Oppenheimer Healthcare Conference 5430 2
...POLIS, May 19 Semafore Pharmaceuticals, Inc., a p...t company, today announced that it will be reporti...pan-PI3K/mTORC1/2 inhibitor, SF1126, during the 20...nual Meeting, being held in Orlando, Florida, May ... Semafore,s vascular targeted pan-PI3K/mTOR inhibi...
...) Element(TM) Stent now available in select market...entific Corporation (NYSE: BSX ) today announced...ent(TM) Paclitaxel-Eluting Coronary Stent System i...nt features a new platinum chromium alloy engineer...d represents the Company,s third-generation drug-e...
Other Medicine Technology:Clinical Data on Semafore's SF1126, a Vascular Targeted Pan-PI3K/mTOR Inhibitor, to be Presented at the 2009 ASCO Meeting 2Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent 2Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent 3Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent 4Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent 5
(Date:11/30/2009)...dy revealed that beverage can pull-tabs were being... manufacturers to stay-tabs. But a study presented...ociety of North America (RSNA) found that the new ... driving factors leading the change in beverage ca...rtent swallowing of the pull-tab and potential rel...
(Date:11/29/2009)... in Europe show a steady decline in mortality betw...om all cancers in the European Union (EU) between ...eight percent in women, with a large drop among th...d online in the cancer journal, Annals of Oncolog...nd that there was an average 185.2 deaths per 100,...
(Date:11/29/2009)...each doctors-in-training how to do ultrasound-guid... skills without compromising patient care and safe...tal. , The study shows that this simulation-base...e medical residents, knowledge, dexterity and conf...asound-guided procedures, including breast biopsie...
(Date:11/29/2009)...reatment equals a $41,000 pay raise, researchers s...) -- Psychological therapy may be much more effect... winning a lottery prize, suggests an English stud...people who provided information about their mental...ss from a $1,329 course of therapy was so signific...
(Date:11/28/2009)...ewswire/ -- Welcome to syngo® .plaza(1)...outine from Siemens Healthcare. As the first ...) from Siemens where 2D, 3D, and 4D reading come...d to change the way multimodality images are read ...he 95th Scientific Assembly and Annual Meeting of ...
Breaking Medicine News(10 mins):Health News:Beverage can stay-tabs pose swallowing risk 2Health News:New figures on cancer in Europe show a steady decline in mortality but big variations 2Health News:New figures on cancer in Europe show a steady decline in mortality but big variations 3Health News:New figures on cancer in Europe show a steady decline in mortality but big variations 4Health News:New figures on cancer in Europe show a steady decline in mortality but big variations 5Health News:Simulated training for ultrasound-guided procedures improves safety without risk to patients 2Health News:Psychotherapy Can Boost Happiness More Than Money: Study 2Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 2Health News:Siemens Healthcare Unveils syngo.plaza at RSNA 2009 3
... Therapeutics Research Institute at Cedars-Sinai M...t is possible to sustain therapeutic gene expressi... even in the presence of an anti-viral immune resp... gutted adenoviral vector called HC-Adv, is comple...
...a multi-stage, multi-mechanism process by animal a...le of Helicobacter pylori (H pylori) in the format... to be published on November 7 in the World Journa...tures necessary for cell differentiation, tissular...
...outcomes, researchers say , THURSDAY, Oct. 25 (Hea...l natriuretic peptide (ANP) can lessen cardiac inj...s, a new study finds. , According to a Japanese st...on injuries," caused when blood rushes back to the...
...,announces the following Webcast: (Logo: http:/... ), What: AMICAS, Inc Webcast, When: November ...wswire.com/event.asp?id=43463 , How: Live over t...ipate during the live webcast, the call will,be ar...
...pare more than 500 health plans ... U.S.News & World Report and the,National Committe...third,edition of America,s Best Health Plans, an a...ilies face health plan,selection options, the rank...
...d radiology groups partners with AMICAS t...ct. 26 AMICAS, Inc. (Nasdaq: AMCS ),a leader in ...ment,solutions, today announced that it has signed... industry,s most comprehensive automation solution...
Other Medicine News:Health News:Helicobacter pylori inhibits intercellular communication of cultured gastric cells 2Health News:U.S.News & World Report, NCQA Release Annual Rankings for 'America's Best Health Plans' 2Health News:U.S.News & World Report, NCQA Release Annual Rankings for 'America's Best Health Plans' 3Health News:Radiology Ltd. Chooses AMICAS as End-to-End Solutions Provider 2Health News:Radiology Ltd. Chooses AMICAS as End-to-End Solutions Provider 3
Nucleus Rotator (Bechert Nucleus Rotator)
Nucleus Spatula & Knife
Sinskey Hook (IOL Hook)
Surpass Superfusion Long
Medicine Products: